Insider Shareholders with Direct Ownership of Io Biotech, Inc. (IOBT)
This section provides a comprehensive overview of the insiders with direct ownership of Io Biotech, Inc. (IOBT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
IO Biotech, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 13,950,686 | 0 | 13,950,686 $13.7 Million | 2 |
Aug 09, 2023
Added 36.16%
|
|
| 5,747,067 | 1,392,618 | 4,354,449 $4.27 Million | 6 |
Jul 26, 2024
Reduced 0.54%
|
|
|
Vivo Capital Ix, Llc
> 10% Shareholder |
3,015,545 | 0 | 3,015,545 $2.96 Million | 1 |
Nov 09, 2021
Added 17.73%
|
|
Hbm Healthcare Investments (Cayman) Ltd.
> 10% Shareholder |
2,690,545 | 0 | 2,690,545 $2.64 Million | 1 |
Nov 09, 2021
Added 10.78%
|
|
Amy Sullivan
Chief Financial Officer |
84,632 | 0 | 84,632 $82,939 | 3 |
Dec 23, 2024
Added 10.8%
|
|
Mai Britt Zocca
Chief Executive Officer |
49,537 | 0 | 49,891 $48,893 | 2 |
Dec 23, 2024
Added 20.03%
|
|
Qasim Iftikhar Ahmad
Chief Medical Officer |
31,350 | 0 | 31,350 $30,723 | 1 |
Dec 23, 2024
Added 50.0%
|
|
Devin Whittemore Smith
General Counsel |
16,938 | 0 | 16,938 $16,599 | 2 |
Dec 23, 2024
Added 41.47%
|
|
Brian Burkavage
Chief Accounting Officer |
10,000 | 0 | 11,500 $11,270 | 2 |
Nov 22, 2023
Added 30.3%
|